USP Strengthens Heparin Standards The US Pharmacopeial Convention’s Expert Panel on Unfractionated Heparin has held a two-day meeting to finalise a third round of revisions to the heparin quality standards. More...
Antibiotic Resistance Programme Launched in Europe The European Federation of Pharmaceutical Industries and Associations (EFPIA) has welcomed the launch of a €223.7-million programme to tackle antimicrobial resistance and speed up the development of new antibiotics. More...
Will WHO Member States Pony Up for Neglected Diseases? Recognising that traditional market forces – namely incentives related to intellectual property and a steady demand for products – have failed in developing countries, the World Health Organisation (WHO) asked a member state-nominated group to come up with ways to fund R&D and pay for the treatment of neglected diseases in the world’s poorest nations. More...
US Industry Comments on Senate Passage of PDUFA V The Pharmaceutical Research and Manufacturers of America (PhRMA) has released a statement regarding the Senate’s vote to pass the Food and Drug Administration Safety and Innovation Act, which reauthorises the Prescription Drug User Fee Act (PDUFA) in the US. More...
All atweet! Keep up to date with the latest news, gossip and rumours hitting the web about the pharmaceutical industry by following us on Twitter. More...
Council of Europe
Scientific Programme Officer - Pharmaceutical Care and Anti-Counterfeiting Programme (Grade A1/A2) Duty station: Strasbourg (France) Ref No: e122/2012 Read more
Product/Service Profiles
Agilent
Realize Effective Pharmaceuticals
Reliable solutions enable pharmaceutical scientists to innovate in disease research, accelerate drug discovery and have greater confidence throughout development and manufacturing. Read more
Agilent
Flex UHPLC Muscle
The Agilent 1290 Infinity LC and ZORBAX Rapid Resolution High Definition (RRHD) columns help you optimize UHPLC separations. Transfer methods from or to other LC systems with Intelligent System Emulation Technology (ISET) on your 1290 Infinity LC and 17 ZORBAX RRHD phases. Request the 1290 Infinity LC/RRHD Pharma Applications Guide.
LB Bohle
Granulation in a new dimension
L.B. Bohle developed an elegant solution for a completely smooth running process in traditional granulation equipment.
The new Compact Unit features a high-shear mixer and fluid bed dryer side by side, complete with sieving step in between. Read more
Marchesini
Marchesini Group is an international leading supplier of automatic packaging machines and complete lines for the pharmaceutical and cosmetic industries. Read more
Powder Systems
PSL will be exhibiting their groundbreaking high containment filter dryer, part of their FilterBox range, at Achema 2012 stand C31, Hall 5.1 . The FilterBox consistis in PSL’s production scale isolator surrounding an ANFD, optimum contained solution for handling cytotoxic compounds. Read more
Tosoh
High Capacity & Robustness for mAb Purification
TOYOPEARL AF-rProtein A-650F affinity resin is well-suited for capturing of antibodies out of high titre feedstocks. It combines a high binding capacity at short residence time and fast mass transfer kinetics with alkaline stability. Read more
Recruitment Profile
Council of Europe
Scientific Programme Officer - Pharmaceutical Care and Anti-Counterfeiting Programme (Grade A1/A2)
Duty station: Strasbourg (France)
Ref No: e122/2012 Read more
Up and Coming Webcasts
Colorcon
WEBCAST: Quality by Design Principles for Film Coating Applications Two.
broadcasts: Wednesday, June 13, 2012 3:00 p.m. IST (India Standard Time) and 10:00 a.m. EDT (Eastern Daylight Time/USA)
Register Free at www.pharmtech.com/coating
Looking forward 10 years from now, what do you think will be the most significant change to drug development and manufacturing?
Fuller adoption of quality by design principles
23%
Greater adoption of continuous manufacturing
6%
A stronger movement to personalized medicine and the use of diagnostics with traditional pharmaceuticals
36%
The rise of biologic-based drugs in commercial product portfolios and pipelines
29%
Greater adoption of the preferred provider model in outsourcing
6%
This week we would like to know...
Do you believe the pharma manufacturing industry is becoming more transparent overall?
